• 제목/요약/키워드: Dipyridamole

검색결과 72건 처리시간 0.03초

관상동맥질환에서 휴식기의 심근관류 정도와 휴식기 심기능 변화의 비교 - Dipyridamole 부하 $^{99m}Tc-MIBI$ SPECT와 휴식기 Gated Blood Pool Scan - (Comparison between Myocardial Perfusion and Function in Rest State in Coronary Artery Disease - Dipyridamole $^{99m}Tc-MIBI$ SPECT and Rest Gated Blood Pool Scan -)

  • 최창운;이동수;김상은;배상균;양형인;정준기;이명묵;이명철;박영배;서정돈;이영우;고창순
    • 대한핵의학회지
    • /
    • 제26권2호
    • /
    • pp.265-273
    • /
    • 1992
  • Rest gated blood pool scan (Rest GBP scan) and dipyridamole $^{99m}Tc-MIBI$ SPECT were Performed in 34 patients with or suspected coronary artery disease. Both studies were performed within $2\sim32$ days (mean 8.1 days). A significant correlation was present between left ventricular ejection fraction (r= -0.7356, p<0.001) and peak ejection rate and peak filling rate in rest GBP scan and perfusion defect in MIBI SPECT. And there were acceptable correlations (0.05$26.2{\pm}10.8%$, severe hypokinesia, akinesia or dyskinesia in 16 regions: $78.2{\pm}23.7$, p<0.001). These data indicate there is a significant coupling between the degree of myocardial perfusion and the myocardial functional change in coronary artery disease.

  • PDF

반복 게이트 심근 Tc-99m-MIBI SPECT로 확인한 디피리다몰 부하에 의한 일과성 심근기절현상 (Transient Prolonged Stunning by Dipyridamole Stress Proved by Post-stress(1 hour) and 24 hour Tc-99m-MIBI Gated SPECT)

  • 이동수;윤석남;이원우;정준기;이명묵;이명철;고창순
    • 대한핵의학회지
    • /
    • 제31권1호
    • /
    • pp.57-66
    • /
    • 1997
  • We performed 1st day Tc-99m-sestamibi gated SPECT with dipyridamole/rest T1-201 SPECT and 2nd day 24 hour delay T1-201 SPECT/rest Tc-99m-sestamibi gated SPECT in 27 patients with coronary artery disease(24) or having chest pain(3). Stress and rest Tc-99m-sestamibi gated SPECT was acquired at 60min post-injection. A 4-point scoring system(0 to 3 for normal to absent tracer uptake) for 17 segments was used. Wall motion was scored on another 4 point scale(0 to 3 for normal to dyskinesia) in the 1st day post-stress gated and the 2nd day rest gated SPECT. Post-stress gated SPECT showed wall motion abnormality in 94 segments(20%). Fifty-five segments among these 94 showed the same wall motion between post-stress and rest gated SPECT: i.e. 1-1 23 segments, 2-2: 29 segments, 3-3: 3 segments. Remaining 39 segments(41.5%) showed different wall motion between post- stress and rest Tc-99m-sestamibi gated SPECT. Twenty one segments with wall motion abnormality had normal perfusion(rest : 15 segments, 24 hour delay: 6 segments) at either rest or 24 hour delay. Fifteen among these 21 segments showed persistent post-stress and the 2nd day rest wall motion abnormality(persistent stunning). However, in 6 segments with pro-longed (1 hour after stress) stunning, abnormal wall motion did improve in the 2nd day rest Tc-99m-sestamibi gated SPECT(transient prolonged stunning). These 6 segments had normal perfusion at rest(n=4) or at 24 hour delay(n=2). Post stress wall motions showed significantly higher scores in persistent stunning than in prolonged transient stunning(P value<0.05). It was concluded that we could find stunned myocardium with gated Tc-99m-sestamibi SPECT at either post-stress or rest and that some myocardial walls of post-stress 1 hour gated SPECT did not show truly rest wall motion. So, we should be cautious if we use post-stress Tc-99m-sestamibi wall motion to assess rest wall motion.

  • PDF

관동맥우회로술 전후의 디피리다몰 부하/휴식 심근 SPECT를 이용한 수술 결과의 평가 (Evaluation of Result of CABG by Comparison of Pre-and Post-operative Myocardial SPECT)

  • 이동수;이원우;강건욱;현인영;김기봉;정준기;이명철;고창순
    • 대한핵의학회지
    • /
    • 제30권1호
    • /
    • pp.86-94
    • /
    • 1996
  • 디피리다몰부하 및 휴식기 심근 SPECT를 통해 수술결과를 평가하였다. 수술전 관류감소를 보이는 분절들의 74%에서 심근관류가 호전되었으며 중증 지속적 관류결손을 보였던 분절도 일부(43%) 수술후 관류가 호전되었다. 관상동맥영역별로는 62%의 영역이 수술후 관류가 호전되었으며, 환자예를 기준으로 하면 수술환자 47%가 수술후 심근관류가 호전되었다. 수술전에 정상이었던 관류가 악화된 예와 수술전 관류보다 나빠진 관류소견을 보이는 예가 있었다. 수술대상 관상동맥을 결정하는데 수술전 부하/심근 SPECT를 참고하여야 할 것인지 조사하여야 한다고 생각하였다.

  • PDF

판막 이식수술후의 각종 항응고제 사용에 관한 비교적 연구 - 조직판막 이식수술후 Warfarin 사용군과 antiplatelet 사용군과의 비교 - (A comparative study on anticoagulants following valve replacement surgery - a retrospective study with warfarin anticoagulation comparing with antiplatelet therapy in patients with bioprosthetic heart valve replacement)

  • 채헌;박영관;서경필
    • Journal of Chest Surgery
    • /
    • 제20권1호
    • /
    • pp.13-21
    • /
    • 1987
  • To clarify the difference between the outcome of warfarin anticoagulation and the antiplatelet [Aspirin, Dipyridamole] therapy after bioprosthetic heart valve replacement, we compared the following two groups. Group I [Warfarin group] consisted of 557 patients undergone lonescu - Shiley valve replacement between January, 1979 and December, 1985, and treated with scheduled warfarin therapy at Seoul National University Hospital. Group II [Antiplatelet group] consisted of 128 patients undergone lonescu - Shiley, Carpentier - Edwards or Wessex bioprosthetic valve replacement between March, 1983 and December, 1986, and treated primarily with antiplatelet therapy [Aspirin plus Dipyridamole] at SeJong General Hospital. The two groups were similar with respect to age, number of valves utilized per patient, type of operation and risk factors of thromboembolism. In group I, 522 patients excluding 35 hospital death [hospital mortality 6.3%], and in group II, 119 survivors excluding 9 hospital death [hospital mortality 7.0%] were followed. In group I, there were 13 fatal complications, of which seven were thromboembolic [0.6% / pt-yr] and six hemorrhagic [0.5%/pt-yr] during the period of four years. In group II, there were 3 fatal thromboembolic complications [2.3%/pt-yr] during the period of four years. This showed no statistically significant difference. Apart from fatal complications, there were lots of warfarin related minor complications in group I comparing with those of group II. The actuarial probability of the freedom from thromboembolism and of the freedom from fatal complications were very similar at each corresponding years postoperatively. As a result, warfarin anticoagulation in patients with bioprosthetic valve replacement did not reveal any significant advantages over antiplatelet therapy.

  • PDF

심장판막질환의 외과적 치료에 관한 임상적 고찰 (Clinical Study of Cardiac Valve Surgery)

  • 박명규;정황규
    • Journal of Chest Surgery
    • /
    • 제20권3호
    • /
    • pp.512-519
    • /
    • 1987
  • In the department of chest surgery of Pusan National University hospital cardiac valve surgery was done in 118 cases from March, 1982, to June, 1986. Among these, 90 were mitral valve replacement, 9 mitral commissurotomy, 5 mitral valvuloplasty, 4 aortic valve replacement, 4 double valve replacement, 4 mitral annuloplasty, one mitral annuloplasty with commissurotomy and valvuloplasty. 48 were male and 70 were female and age distribution ranged from 6 to 57 years [mean 30.6 years]. Early death within 30 days after operation was 14 cases: 10 had mitral valve replacement, 2 double valve replacement and 2 mitral annuloplasty respectively. Confirmed causes of death were low cardiac output syndrome in 9 cases, congestive heart failure in one case, cardiac tamponade in one case, malfunction of valve in one case, cardiac rupture in one case and renal failure in one case. The 104 cases were followed up for a total 190 years and range was from 2 to 54 months [Mean*SD: 21.9*16.5 months]. During follow-up period, 2 late deaths were developed: one was due to subdural hematoma and the other was congestive heart failure combined with fulminant hepatitis. Anticoagulation therapy was done with warfarin to the level of 20 to 40% of normal prothrombin time in 53 cases, dipyridamole and aspirin in 18 cases, or ticlopidine hcl in 15 cases. The frequency of bleeding due to anticoagulation therapy was 1.0% episodes per patient-years: one was in warfarin group and another was in dipyridamole and aspirin group. Among the studied 102 cases, 93 cases [91.2%] of patients were in NYHA class I or II during follow up period.

  • PDF